Porton Pharma Solutions Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	1,131	1,475	1,967	2,850	1,217
Trading Asset Securities	279.28	-	-	-	-
Cash & Short-Term Investments	1,411	1,475	1,967	2,850	1,217
Cash Growth	-4.34%	-25.02%	-31.01%	134.24%	-3.90%
Accounts Receivable	797.47	829.5	690.57	1,506	1,088
Other Receivables	45.57	36.4	44.99	60.91	66.74
Receivables	843.05	865.9	735.56	1,567	1,154
Inventory	770.38	771.31	717.07	902.2	757.39
Other Current Assets	250.37	129.63	235.13	142.9	82.2
Total Current Assets	3,274	3,241	3,654	5,463	3,211
Property, Plant & Equipment	3,879	4,100	4,212	3,381	2,316
Long-Term Investments	362.8	347.15	388.03	372.65	377.13
Goodwill	290.46	292.91	291.29	330.11	280.43
Other Intangible Assets	251.7	258.75	275.16	267.1	130.8
Long-Term Deferred Tax Assets	51.12	64.19	74.68	62.79	58.92
Long-Term Deferred Charges	406.5	426.35	430.39	159.66	63.79
Other Long-Term Assets	34.89	85.4	58.11	108.33	123.54
Total Assets	8,551	8,816	9,384	10,144	6,562
Accounts Payable	844.7	899.26	796.14	1,788	1,111
Accrued Expenses	180.92	183.56	196.32	490.75	210.18
Short-Term Debt	10	66.01	20.03	303.35	389.66
Current Portion of Long-Term Debt	486.99	329.41	216.01	69.09	95.27
Current Portion of Leases	-	55.73	45.42	31.08	24.5
Current Income Taxes Payable	26.67	10.89	6.17	55.88	34.83
Current Unearned Revenue	181.4	100.98	57.5	73.63	63.68
Other Current Liabilities	65.28	59.35	53.81	204.3	189.38
Total Current Liabilities	1,796	1,705	1,391	3,016	2,119
Long-Term Debt	481.28	908.98	1,070	312.91	24
Long-Term Leases	532	595.99	621.38	207.33	207.34
Long-Term Unearned Revenue	168.7	147.98	109.99	65.25	18.26
Long-Term Deferred Tax Liabilities	74.82	46.78	91.04	70.52	7.79
Total Liabilities	3,053	3,405	3,284	3,672	2,376
Common Stock	543.44	545.46	546.04	546.03	544.4
Additional Paid-In Capital	1,943	2,041	2,067	1,958	1,799
Retained Earnings	2,839	2,742	3,293	3,628	1,728
Treasury Stock	-29.87	-129.85	-135.27	-133.1	-61.83
Comprehensive Income & Other	55.27	-0.89	29.24	4.28	-27.3
Total Common Equity	5,351	5,198	5,801	6,003	3,982
Minority Interest	147.44	213.2	299.17	469.17	204.53
Shareholders' Equity	5,498	5,411	6,100	6,472	4,186
Total Liabilities & Equity	8,551	8,816	9,384	10,144	6,562
Total Debt	1,510	1,956	1,973	923.77	740.77
Net Cash (Debt)	-99.74	-481.6	-6.61	1,927	476.1
Net Cash Growth	-	-	-	304.68%	-53.09%
Net Cash Per Share	-0.19	-0.89	-0.01	3.55	0.88
Filing Date Shares Outstanding	542.58	542.18	546.04	546.03	544.4
Total Common Shares Outstanding	542.58	542.18	546.04	546.03	544.4
Working Capital	1,478	1,536	2,263	2,447	1,092
Book Value Per Share	9.86	9.59	10.62	10.99	7.31
Tangible Book Value	4,809	4,646	5,234	5,406	3,570
Tangible Book Value Per Share	8.86	8.57	9.59	9.90	6.56
Buildings	-	990.29	1,003	800.28	647.71
Machinery	-	3,545	3,120	2,335	1,820
Construction In Progress	-	437.4	693.46	1,029	341.58

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.